Correction of vitamin D deficiency improves seizure control in epilepsy: A pilot study

Epilepsy and Behavior

Volumn 24, Issue 1, 2012, Pages 131-133

  Holló, András ^a   Clemens, Zsófia ^b   Kamondi, Anita ^b   Lakatos, Péter ^c   Szucs, Anna ^b  

^a National Institute for Medical Rehabilitation   (Hungary)

^b National Institute of Neuroscience   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Hypovitaminosis D; Neurosteroids; Pharmacoresistant epilepsy; Seizure control; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL;

ADULT; AGED; ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE CONTROL; DISEASE DURATION; EPILEPSY; FEMALE; HUMAN; INCIDENCE; MALE; PILOT STUDY; SEIZURE; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; AGED; CHOLECALCIFEROL; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84860677149     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.03.011     Document Type: Article

References (26)

1. Garland C.F., Garland F.C., Gorham E.D., et al. The role of vitamin D in cancer prevention. Am J Public Health 2006, 96:252-261.
2. Vacek J.L., Vanga S.R., Good M., Lai S.M., Lakkireddy D., Howard P.A. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012, 109:359-363.
3. Bikle D.D. Vitamin D and the immune system: role in protection against bacterial infection. Curr Opin Nephrol Hypertens 2008, 17:348-352.
4. Pittas A.G., Dawson-Hughes B. Vitamin D and diabetes. J Steroid Biochem Mol Biol 2010, 121:425-429.
5. Melamed M.L., Michos E.D., Post W., Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
6. Evatt M.L., Delong M.R., Khazai N., Rosen A., Triche S., Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008, 65:1348-1352.
7. Buell J.S., Dawson-Hughes B., Scott T.M., et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74:18-26.
8. Knekt P., Kilkkinen A., Rissanen H., Marniemi J., Sääksjärvi K., Heliövaara M. Serum vitamin D and the risk of Parkinson disease. Arch Neurol 2010, 67:808-811.
9. Mowry E.M. Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis. J Neurol Sci 2011, 311:19-22.
10. McGrath J.J., Burne T.H., Féron F., Mackay-Sim A., Eyles D.W. Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update. Schizophr Bull 2010, 36:1073-1078.
11. Mintzer S., Boppana P., Toguri J., DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006, 47:510-515.
12. Lee R.H., Lyles K.W., Colón-Emeric C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 2010, 8:34-46.
13. Shellhaas R.A., Joshi S.M. Vitamin D and bone health among children with epilepsy. Pediatr Neurol 2010, 42:385-393.
14. Christiansen C., Rodbro P., Sjö O. "Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study. Br Med J 1974, 2:258-259.
15. Oki J., Takedatsu M., Itoh J., Yano K., Cho K., Okuno A. Hypocalcemic focal seizures in a one-month-old infant of a mother with a low circulating level of vitamin D. Brain Dev 1991, 13:132-134.
16. Agarwal K.S., Beri R.S., Puliyel J.M. Repeated unifocal seizure in post neonatal infants with hypocalcemia. Indian Pediatr 2000, 37:203-205.
17. Dijkstra S.H., Arpaci G., Huijsman W.A., Boot A.M., van den Akker E.L. Seizures in foreign newborns due to maternal vitamin-D deficiency. Ned Tijdschr Geneeskd 2005, 149:257-260.
18. Camadoo L., Tibbott R., Isaza F. Maternal vitamin D deficiency associated with neonatal hypocalcaemic convulsions. Nutr J 2007, 6:23.
19. Siegel A., Malkowitz L., Moskovits M.J., Christakos S. Administration of 1,25 dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res 1984, 298:125-129.
20. Kalueff A.V., Minasyan A., Keisala T., Kuuslahti M., Miettinen S., Tuohimaa P. Increased severity of chemically induced seizures in mice with partially deleted vitamin D receptor gene. Neurosci Lett 2006, 394:69-73.
21. Borowicz K.K., Morawska M., Furmanek-Karwowska K., Luszczki J.J., Czuczwar S.J. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur J Pharmacol 2007, 573:111-115.
22. Kwan P., Arzimanoglou A., Berg A.T., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010, 51:1069-1077.
23. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911-1930.
24. Eyles D.W., Smith S., Kinobe R., Hewison M., McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005, 29:21-30.
25. Stewart A., Wong K., Cachat J., et al. Neurosteroid vitamin D system as a nontraditional drug target in neuropsychopharmacology. Behav Pharmacol 2010, 21:420-426.
26. Ramagopalan S.V., Heger A., Berlanga A.J., et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res 2010, 20:1352-1360.